VMS Rehab Systems, Inc.

VMS Rehab Systems, Inc.

VRSYF
VMS Rehab Systems, Inc.US flagOther OTC
0.00
USD
- -
- -
156,166.00Market Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Michael S. Wexler
Sector
Healthcare
Industry
Medical - Devices
Address
440 Laurier Avenue West Ottawa ON Canada K1R 7X6
IPO Date
May 1, 2015
Business
VMS Rehab Systems, Inc. (Ticker: VRSYF) develops and provides specialized rehabilitation equipment and therapy solutions for physical and occupational therapy applications. The company offers core products including powered therapy tables, adjustable treatment couches, electrotherapy devices, resistance band systems, and modular rehab stations; services encompass equipment leasing, maintenance contracts, and customized therapy room design consultations. VMS targets healthcare providers such as clinics, hospitals, and rehabilitation centers primarily in North America, with operations extending to select international markets in Europe and Asia. Founded in 1992 and headquartered in Richmond, British Columbia, Canada, the company operates as an independent entity focused on the medical device segment of the healthcare industry. In the past year, VMS Rehab Systems announced a strategic partnership with Apex Medical Technologies for expanded distribution of its powered rehab tables in the U.S. market and completed a C$5 million funding round in Q3 2025 to support new product launches, including the VMS FlexPro adaptive resistance system; additionally, the company acquired RehabTech Innovations, a small developer of digital therapy tracking software, to integrate smart monitoring features into its equipment lineup.